These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7115318)

  • 1. The effects of lactoyl-pepstatin and the pepsin inhibitor peptide on pig cathepsin D.
    Kay J; Afting EG; Aoyagi T; Dunn BM
    Biochem J; 1982 Jun; 203(3):795-7. PubMed ID: 7115318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activity of aspartic proteinase inhibitors related to pepstatin.
    Gunn JM; Owens RA; Liu WS; Glover GI
    Acta Biol Med Ger; 1981; 40(10-11):1547-53. PubMed ID: 6805191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of human cathepsin D with the inhibitor pepstatin.
    Knight CG; Barrett AJ
    Biochem J; 1976 Apr; 155(1):117-25. PubMed ID: 938470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional brain distribution of cathepsin D activity: its inhibition in vivo following central infusion of pepstatin in the rat.
    Buccafusco JJ; Goldstein BD; Greenbaum LM
    Res Commun Chem Pathol Pharmacol; 1982 Apr; 36(1):157-60. PubMed ID: 7079582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pepstatin inhibition mechanism.
    Marciniszyn J; Hartsuck JA; Tang J
    Adv Exp Med Biol; 1977; 95():199-210. PubMed ID: 339690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dinitrophenyl-pepstatins as active-site-directed localization reagents for cathepsin D.
    Matthews IT; Decker RS; Hornebeck W; Knight CG
    Biochem J; 1983 Apr; 211(1):139-47. PubMed ID: 6347185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pepstatin inhibition of cathepsin D in situ and its modification of leukokinin formation: HPLC separation of fluorescamine-treated kinins.
    Greenbaum LM; Sutherland JH; Narayan TK
    Adv Exp Med Biol; 1983; 156 (Pt B)():783-7. PubMed ID: 6190383
    [No Abstract]   [Full Text] [Related]  

  • 8. The inhibition by pepstatin of cathepsin D and autolysis of dystrophic muscle.
    Iodice AA
    Life Sci; 1976 Nov; 19(9):1351-8. PubMed ID: 11385
    [No Abstract]   [Full Text] [Related]  

  • 9. Bimane-labelled pepstatin, a fluorescent probe for the subcellular location of cathepsin D.
    Matthews IT; Decker RS; Knight CG
    Biochem J; 1981 Dec; 199(3):611-7. PubMed ID: 7340822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of inhibition of acid proteases by pepstatin.
    Marciniszyn J; Hartsuck JA; Tang J
    J Biol Chem; 1976 Nov; 251(22):7088-94. PubMed ID: 993206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of Triiodothyronine-induced tadpole tail-fin regression by cathepsin D-inhibitor pepstatin.
    Seshimo H; Ryuzaki M; Yoshizato K
    Dev Biol; 1977 Aug; 59(1):96-100. PubMed ID: 302228
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of thyroid cathepsin D activity by pepstatin.
    Starling JR; Hopps BA
    J Surg Res; 1980 Jan; 28(1):8-13. PubMed ID: 6153736
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of dinitrophenyl-pepstatins with human cathepsin D and with anti-dinitrophenyl antibody. Development of potential reagents for the localization in vivo of active proteinases at sites of tissue injury.
    Knight CG; Hornebeck W; Matthews IT; Hembry RM; Dingle JT
    Biochem J; 1980 Dec; 191(3):835-43. PubMed ID: 6793037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition.
    Rich DH; Bernatowicz MS; Agarwal NS; Kawai M; Salituro FG; Schmidt PG
    Biochemistry; 1985 Jun; 24(13):3165-73. PubMed ID: 3927973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cysteine proteinase activity by Z-Phe-Phe-diazomethane and of aspartic proteinase activity by pepstatin in different organs from some animals and isolated cells from rat liver.
    Riemann S; Kirschke H; Wiederanders B; Brouwer A; Shaw E; Bohley P
    Acta Biol Med Ger; 1982; 41(1):83-8. PubMed ID: 7051705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cathepsin D by substrate analogues containing statine and by analogues of pepstatin.
    Agarwal NS; Rich DH
    J Med Chem; 1986 Dec; 29(12):2519-24. PubMed ID: 3783611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of in vivo inhibition of tissue cathepsin D by pepstatin A.
    Leto G; Tumminello FM; Gebbia N; Rausa L
    Int J Biochem; 1988; 20(9):917-20. PubMed ID: 3197907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New renin inhibitors homologous with pepstatin.
    Eid M; Evin G; Castro B; Menard J; Corvol P
    Biochem J; 1981 Aug; 197(2):465-71. PubMed ID: 7034718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pepstatin inhibition studies on individual human pepsins and pepsinogens 1,3 and 5(gastricsin) and pig pepsin A.
    Roberts NB; Taylor WH
    J Enzyme Inhib Med Chem; 2003 Jun; 18(3):209-17. PubMed ID: 14506911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isolation of cathepsin D from the aorta using pepstatin sepharose].
    Pichugin AL; Kazakova OV
    Vopr Med Khim; 1979; 25(6):741-3. PubMed ID: 516535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.